Construction and Analysis of the Protein-Protein Interaction Networks Based on Gene Expression Profiles of Parkinson's Disease

Background Parkinson's Disease (PD) is one of the most prevailing neurodegenerative diseases. Improving diagnoses and treatments of this disease is essential, as currently there exists no cure for this disease. Microarray and proteomics data have revealed abnormal expression of several genes and proteins responsible for PD. Nevertheless, few studies have been reported involving PD-specific protein-protein interactions. Results Microarray based gene expression data and protein-protein interaction (PPI) databases were combined to construct the PPI networks of differentially expressed (DE) genes in post mortem brain tissue samples of patients with Parkinson's disease. Samples were collected from the substantia nigra and the frontal cerebral cortex. From the microarray data, two sets of DE genes were selected by 2-tailed t-tests and Significance Analysis of Microarrays (SAM), run separately to construct two Query-Query PPI (QQPPI) networks. Several topological properties of these networks were studied. Nodes with High Connectivity (hubs) and High Betweenness Low Connectivity (bottlenecks) were identified to be the most significant nodes of the networks. Three and four-cliques were identified in the QQPPI networks. These cliques contain most of the topologically significant nodes of the networks which form core functional modules consisting of tightly knitted sub-networks. Hitherto unreported 37 PD disease markers were identified based on their topological significance in the networks. Of these 37 markers, eight were significantly involved in the core functional modules and showed significant change in co-expression levels. Four (ARRB2, STX1A, TFRC and MARCKS) out of the 37 markers were found to be associated with several neurotransmitters including dopamine. Conclusion This study represents a novel investigation of the PPI networks for PD, a complex disease. 37 proteins identified in our study can be considered as PD network biomarkers. These network biomarkers may provide as potential therapeutic targets for PD applications development.

[1]  S. Bandyopadhyay,et al.  Studying the System-Level Involvement of MicroRNAs in Parkinson's Disease , 2014, PLoS ONE.

[2]  Tatiana Foroud,et al.  Parkinson Disease Overview , 2014 .

[3]  Lian-bo Gao,et al.  Gene expression profiling analysis of the putamen for the investigation of compensatory mechanisms in Parkinson’s disease , 2013, BMC Neurology.

[4]  R. Williams,et al.  Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice , 2013, Neuroscience.

[5]  Sebastian Munck,et al.  β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease , 2013, Nature Medicine.

[6]  A. Hansson,et al.  β-Arrestin 2 knockout mice exhibit sensitized dopamine release and increased reward in response to a low dose of alcohol , 2013, Psychopharmacology.

[7]  Ling Liu,et al.  Construction and analysis of the protein-protein interaction network related to essential hypertension , 2013, BMC Systems Biology.

[8]  Avi Ma'ayan,et al.  Genes2FANs: connecting genes through functional association networks , 2012, BMC Bioinformatics.

[9]  J. Vance,et al.  Gene Expression Profiles in Parkinson Disease Prefrontal Cortex Implicate FOXO1 and Genes under Its Transcriptional Regulation , 2012, PLoS genetics.

[10]  K. Akagawa,et al.  Impairment of Catecholamine Systems during Induction of Long-Term Potentiation at Hippocampal CA1 Synapses in HPC-1/Syntaxin 1A Knock-out Mice , 2012, The Journal of Neuroscience.

[11]  Rafael C. Jimenez,et al.  The IntAct molecular interaction database in 2012 , 2011, Nucleic Acids Res..

[12]  Cheng-Yan Kao,et al.  Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression , 2011, BMC Bioinformatics.

[13]  E. Hattori,et al.  Replication study of Japanese cohorts supports the role of STX1A in autism susceptibility , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  I. Ferrer,et al.  Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease , 2011, Journal of Neural Transmission.

[15]  Todd F. DeLuca,et al.  Genotator: A disease-agnostic tool for genetic annotation of disease , 2010, BMC Medical Genomics.

[16]  J. Foster,et al.  Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression , 2010, Neuroscience.

[17]  Lisa M. Wiedholz,et al.  Does gene deletion of AMPA GluA1 phenocopy features of schizoaffective disorder? , 2010, Neurobiology of Disease.

[18]  Joaquín Dopazo,et al.  Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling , 2010, Nucleic Acids Res..

[19]  I. Ferrer,et al.  Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment , 2010, Acta Neuropathologica.

[20]  P. Barone,et al.  Neurotransmission in Parkinson’s disease: beyond dopamine , 2010, European journal of neurology.

[21]  F. Benfenati,et al.  Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex: analysis of synaptogyrin, vesicle-associated membrane protein, and syntaxin , 2010, Neuroscience.

[22]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..

[23]  Hans-Werner Mewes,et al.  CORUM: the comprehensive resource of mammalian protein complexes , 2007, Nucleic Acids Res..

[24]  Tzu-Chi Chen,et al.  Cliques in mitotic spindle network bring kinetochore‐associated complexes to form dependence pathway , 2009, Proteomics.

[25]  Bing Qi,et al.  Phosphorylation of myristoylated alanine-rich C kinase substrate is involved in the cAMP-dependent amylase release in parotid acinar cells. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[26]  A. Brice,et al.  Parkinson's disease: from monogenic forms to genetic susceptibility factors. , 2009, Human molecular genetics.

[27]  David Warde-Farley,et al.  Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.

[28]  Sandhya Rani,et al.  Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..

[29]  Tzu-Chi Chen,et al.  POINeT: protein interactome with sub-network analysis and hub prioritization , 2009, BMC Bioinformatics.

[30]  E. Hattori,et al.  Genetic and expression analyses reveal elevated expression of syntaxin 1A ( STX1A) in high functioning autism. , 2008, The international journal of neuropsychopharmacology.

[31]  Ozlem Keskin,et al.  Topological properties of protein interaction networks from a structural perspective. , 2008, Biochemical Society transactions.

[32]  Weixiong Zhang,et al.  Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases , 2008, Genome Biology.

[33]  Matthew R. Laird,et al.  Protein Protein Interaction Network Evaluation for Identifying Potential Drug Targets , 2009 .

[34]  C. Davie A review of Parkinson's disease. , 2008, British medical bulletin.

[35]  Pablo Villoslada,et al.  A computational analysis of protein-protein interaction networks in neurodegenerative diseases , 2008, BMC Systems Biology.

[36]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[37]  Caroline C. Friedel,et al.  Influence of degree correlations on network structure and stability in protein-protein interaction networks , 2007, BMC Bioinformatics.

[38]  J. Dopazo,et al.  FatiGO +: a functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments , 2007, Nucleic Acids Res..

[39]  Mark Gerstein,et al.  The Importance of Bottlenecks in Protein Networks: Correlation with Gene Essentiality and Expression Dynamics , 2007, PLoS Comput. Biol..

[40]  Gabriele Ausiello,et al.  MINT: the Molecular INTeraction database , 2006, Nucleic Acids Res..

[41]  Mark Gerstein,et al.  The tYNA platform for comparative interactomics: a web tool for managing, comparing and mining multiple networks , 2006, Bioinform..

[42]  Mike Tyers,et al.  Evolutionary and Physiological Importance of Hub Proteins , 2006, PLoS Comput. Biol..

[43]  Jianzhi Zhang,et al.  Why Do Hubs Tend to Be Essential in Protein Networks? , 2006, PLoS genetics.

[44]  Mike Tyers,et al.  BioGRID: a general repository for interaction datasets , 2005, Nucleic Acids Res..

[45]  Hans-Werner Mewes,et al.  MPact: the MIPS protein interaction resource on yeast , 2005, Nucleic Acids Res..

[46]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[47]  L. Moran,et al.  Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson’s disease , 2006, Neurogenetics.

[48]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[49]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[50]  S. Coulomb,et al.  Gene essentiality and the topology of protein interaction networks , 2005, Proceedings of the Royal Society B: Biological Sciences.

[51]  Prahlad T. Ram,et al.  Formation of Regulatory Patterns During Signal Propagation in a Mammalian Cellular Network , 2005, Science.

[52]  D. Ingber,et al.  High-Betweenness Proteins in the Yeast Protein Interaction Network , 2005, Journal of biomedicine & biotechnology.

[53]  Shoshana J. Wodak,et al.  CYGD: the Comprehensive Yeast Genome Database , 2004, Nucleic Acids Res..

[54]  Dmitrij Frishman,et al.  MIPS: analysis and annotation of proteins from whole genomes in 2005 , 2005, Nucleic Acids Res..

[55]  Rafael A. Irizarry,et al.  A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .

[56]  C. Sander,et al.  The HUPO PSI's Molecular Interaction format—a community standard for the representation of protein interaction data , 2004, Nature Biotechnology.

[57]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[58]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[59]  N. Hattori,et al.  Parkin Cleaves Intracellular α-Synuclein Inclusions via the Activation of Calpain* , 2003, Journal of Biological Chemistry.

[60]  L. Mirny,et al.  Protein complexes and functional modules in molecular networks , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[61]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[62]  N. Hattori,et al.  Parkin cleaves intracellular alpha-synuclein inclusions via the activation of calpain. , 2003, The Journal of biological chemistry.

[63]  Robert Tibshirani,et al.  SAM “Significance Analysis of Microarrays” Users guide and technical document , 2002 .

[64]  Isabel Rojas,et al.  A graph layout algorithm for drawing metabolic pathways , 2001, Bioinform..

[65]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Ian M. Donaldson,et al.  BIND: the Biomolecular Interaction Network Database , 2001, Nucleic Acids Res..

[67]  Ioannis Xenarios,et al.  DIP: the Database of Interacting Proteins , 2000, Nucleic Acids Res..

[68]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[69]  Hong Yang,et al.  Regulation of Angiotensin II–induced Neuromodulation by MARCKS in Brain Neurons , 1998, The Journal of cell biology.

[70]  P. Greengard,et al.  Localization of the MARCKS (87 kDa) protein, a major specific substrate for protein kinase C, in rat brain , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.